Luminelle
UVision360, a femtech provider, offers the LUMINELLE DTx System for efficient Hysteroscopy & Cystoscopy procedures.
Founded
2016UVision360, a femtech provider, offers the LUMINELLE DTx System for efficient Hysteroscopy & Cystoscopy procedures.
Founded by UVision360, Luminelle is a pioneering femtech company dedicated to advancing women's health through innovative medical technology. The company's core mission is to provide accessible, cost-effective solutions for gynecological procedures, specifically focusing on office-based Hysteroscopy and Cystoscopy. Their flagship product, the LUMINELLE DTx System, enables early diagnosis and treatment of uterine conditions, offering a convenient alternative to traditional hospital settings. Luminelle aims to enhance patient care while reducing healthcare costs, targeting both medical professionals and patients in the women's health market.
Luminelle has garnered attention from notable figures in the medical and investment communities, including a distinguished Board of Directors and Medical Advisory Board. The company has achieved significant milestones, such as gaining regulatory approvals and expanding its market presence. By streamlining diagnostic and procedural workflows, Luminelle has made a substantial impact on women's health, improving early detection and treatment outcomes for uterine cancer and other conditions.
Companies similar to Luminelle include Meditrina, UE LifeSciences, Femasys and Bright Uro.
Luminelle was founded in 2016.
Luminelle's headquarters is located in Raleigh, NC, US.
Luminelle's most recent funding round was for $3.5M (USD) in May 2021.
As of May 7, 2021, Luminelle has disclosed funding of $8.1M (USD). Undisclosed round amounts are excluded.
Luminelle has 6 employees as of Feb 4, 2024.
brighturo.com
